Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

NCT01046214 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment issues

Conditions

Depressive Disorder

Interventions

DRUG: Bupropion HCl
DRUG: Bupropion HCl

Sponsor

Teva Pharmaceuticals USA